↓ Skip to main content

Docetaxel with or without estramustine for estramustine refractory castration-resistant prostate cancer: a single institution experience

Overview of attention for article published in BMC Urology, February 2012
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
17 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Docetaxel with or without estramustine for estramustine refractory castration-resistant prostate cancer: a single institution experience
Published in
BMC Urology, February 2012
DOI 10.1186/1471-2490-12-3
Pubmed ID
Authors

Kazuhiko Nakano, Shigeyuki Ohta, Kenji Komatsu, Taro Kubo, Akinori Nukui, Kazumi Suzuki, Shinsuke Kurokawa, Minoru Kobayashi, Tatsuo Morita

Abstract

The significance of combination of docetaxel (DTX) with estramustine phosphate (EMP) in castration-resistant prostate cancer (CRPC) patients remains unclear. In this study, we aimed to retrospectively evaluate the efficacy and toxicity of DTX with or without EMP and to elucidate the significance of DTX and EMP combination therapy in Japanese EMP-refractory CRPC patients.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 17 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 3 18%
Student > Bachelor 3 18%
Student > Doctoral Student 2 12%
Other 1 6%
Professor 1 6%
Other 2 12%
Unknown 5 29%
Readers by discipline Count As %
Medicine and Dentistry 7 41%
Computer Science 1 6%
Sports and Recreations 1 6%
Engineering 1 6%
Unknown 7 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 February 2012.
All research outputs
#18,304,874
of 22,663,150 outputs
Outputs from BMC Urology
#515
of 740 outputs
Outputs of similar age
#121,559
of 156,341 outputs
Outputs of similar age from BMC Urology
#4
of 4 outputs
Altmetric has tracked 22,663,150 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 740 research outputs from this source. They receive a mean Attention Score of 4.9. This one is in the 13th percentile – i.e., 13% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 156,341 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 9th percentile – i.e., 9% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one.